New technologies in cancer. Protein microarrays for biomarker discovery

被引：0
|
作者：
Sergio Matarraz
María González-González
María Jara
Alberto Orfao
Manuel Fuentes
机构：
[1] University of Salamanca,Centro de Investigación del Cáncer/IBMCC (USAL/CSIC) Departamento de Medicina y Servicio General de Citometría
来源：
Clinical and Translational Oncology | 2011年 / 13卷
关键词：
Biomarkers; Protein arrays; Functional proteomics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The emergence of proteomic techniques and methodological approaches to study disease has kindled the quest for new biomarkers. Thus, the use of protein microarrays has surged as a powerful tool for large-scale testing of biological samples. In this mini-review, we will discuss the application of protein microarray technologies that offer unique opportunities to find novel biomarkers.
引用
收藏
页码：156 / 161
页数：5
相关论文
共 50 条
  • [41] New era of integrated cancer biomarker discovery using reverse-phase protein arrays
    Nishizuka, Satoshi S.
    Mills, Gordon B.
    DRUG METABOLISM AND PHARMACOKINETICS, 2016, 31 (01) : 35 - 45
  • [42] Cancer protein biomarker discovery based on nucleic acid aptamers
    Xiong, Hongjie
    Yan, Jianhua
    Cai, Shundong
    He, Qunye
    Peng, Dongming
    Liu, Zhenbao
    Liu, Yanfei
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 132 : 190 - 202
  • [43] Protein Array-based Approaches for Biomarker Discovery in Cancer
    Huang, Yi
    Zhu, Heng
    GENOMICS PROTEOMICS & BIOINFORMATICS, 2017, 15 (02) : 73 - 81
  • [44] Enroute to protein biomarker discovery for early detection of cervical cancer
    Panicker, Gitika
    Emanuele, Vincent A., II
    Gurbaxani, Brian M.
    Lee, Daisy R.
    Unger, Elizabeth R.
    CANCER BIOMARKERS, 2008, 4 (03) : 165 - 166
  • [45] Protein Array-based Approaches for Biomarker Discovery in Cancer
    Yi Huang
    Heng Zhu
    Genomics,Proteomics & Bioinformatics, 2017, (02) : 73 - 81
  • [46] An update on using protein microarrays in drug discovery
    Kumble, Krishnanand D.
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (11) : 1467 - 1476
  • [47] Genomic microarrays, in cancer molecular diagnostics: just biomarker discovery tools or future bedside clinical assays?
    Ross, JS
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2005, 5 (06) : 837 - 838
  • [48] A serum protein biomarker signature for the detection of early stages of ovarian cancer.
    Skubitz, Amy P.
    Boylan, Kristin L.
    Starr, Timothy K.
    Pu, Xuan
    Cao, Qing
    Geschwind, Kate
    Bast, Robert C., Jr.
    Lu, Karen H.
    Celestino, Joseph
    Petersen, Ashley J.
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 102 - 103
  • [49] Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer
    Aldea, M.
    Clofent, J.
    Nunez de Arenas, C.
    Chamorro, M.
    Velasco, M.
    Berrendero, J. R.
    Navarro, C.
    Cuezva, J. M.
    CANCER LETTERS, 2011, 311 (02) : 210 - 218
  • [50] Biomarker discovery and validation:: technologies and integrative approaches
    Ilyin, SE
    Belkowski, SM
    Plata-Salamán, CR
    TRENDS IN BIOTECHNOLOGY, 2004, 22 (08) : 411 - 416
12345